Utama › Kanser (semua jenis) › Texas › Irving
Kajian klinikal Kanser (semua jenis) di Irving, TX
15 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Irving (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
REC-7735 in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology - Dallas, Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- NEXT Dallas, Irving
Registry Study for Radiation Therapy Outcomes
Mengambil pesertaKajian pemerhatian
- Texas Center for Proton Therapy, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Mengambil pesertaFasa 3
- US Oncology Research Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Dallas, Irving
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Mengambil pesertaFasa 1
- NEXT Oncology ( Site 0051), Irving
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Mengambil pesertaFasa 1/2
- NEXT Oncology ( Site 1012), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Mengambil pesertaFasa 1/2
- NEXT Oncology Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Dallas, Irving
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Dallas, Irving
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Dallas, Irving
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Mengambil pesertaFasa 1
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Mengambil pesertaFasa 1/2
- NEXT Dallas, Irving
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
Mengambil pesertaKajian pemerhatian
- Texas Center for Proton Therapy, Irving
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
Kajian lain di Irving
- Kanser Paru-paru Bukan Sel Kecil22 kajian
- Kanser Kolorektal13 kajian
- Kanser Metastatik11 kajian
- Kanser Pankreas7 kajian
- Kanser Perut7 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher6 kajian
- Kanser Payudara6 kajian
- Kanser Paru-paru Sel Kecil6 kajian
- Kanser Paru-paru6 kajian
- Kanser Ovari5 kajian
- Kanser Endometrium4 kajian
- Kanser Prostat4 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.